Global Synthetic Biology Market 2014-2018

Global Synthetic Biology Market 2014-2018

Category : Healthcare
Published On : July  2014
Pages : 74



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

About Synthetic Biology 
The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones.  The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.
TechNavio's analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.
Covered in this Report
The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems. 

TechNavio's report, the Global Synthetic Biology Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
• APAC
Key Vendors
• Amyris Inc.
• E. I. du Pont de Nemours and Co. 
• Thermo Fisher Scientific Inc. 
• Synthetic Genomics Inc.
Other Prominent Vendors
• Algenol Biofuels Inc.
• ATG:biosynthetics GmbH
• Bayer AG
• Bioneer Corp. 
• Biosearch Technologies Inc.
• Bristol-Myers Squibb Co. 
• CBC Comprehensive Biomarker Center GmbH
• Cobalt Technologies
• Evolva Holdings SA
• Exxon Mobil Corp. 
• GeneWorks Pty Ltd.
• Genomatica Inc.
• Gevo Inc.
• Ginkgo Bioworks 
• Green Biologics Ltd.
• New England Biolabs Inc.
• OriGene Technologies Inc.
• REG Life Sciences LLC
• Royal DSM
• Synthorx Inc.
Key Market Driver
• Increased R&D in Synthetic Biology
• For a full, detailed list, view our report.
Key Market Challenge
• Lack of Modularized Biological Parts
• For a full, detailed list, view our report.
Key Market Trend
• Growing Demand for GM Crops
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


03.1 Market Overview

03.2 Product and Service Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape


06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Product

09. Market Segmentation by Applications

10. Geographical Segmentation


10.1 Synthetic Biology Market in the Americas

10.1.1 Market Size and Forecast

10.2 Synthetic Biology Market in the EMEA Region

10.2.1 Market Size and Forecast

10.3 Synthetic Biology Market in the APAC Region

10.3.1 Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape


18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Vendor Share Analysis 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 Amyris Inc.

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Business Strategy

19.1.4 Geographical Segmentation

19.1.5 Key Developments

19.1.6 SWOT Analysis

19.1.7 Strengths

19.1.8 Weakness

19.1.9 Opportunities

19.1.10 Threats

19.2 E. I. du Pont de Nemours and Company

19.2.1 Key Facts

19.2.2 Business Description

19.2.3 Business Segmentation

19.2.4 Business Strategy

19.2.5 Revenue Segmentation

19.2.6 Revenue Comparison  2013-2011

19.2.7 Geographical Segmentation

19.2.8 Key Developments

19.2.9 SWOT Analysis

19.2.10 Strengths

19.2.11 Weakness

19.2.12 Opportunities

19.2.13 Threats

19.3 Synthetic Genomics, Inc.

19.3.1 Key Facts

19.3.2 Business Overview/ Description

19.3.3 Business Strategy

19.3.4 Key Information

19.3.5 SWOT Analysis

19.3.6 Strengths

19.3.7 Weakness

19.3.8 Opportunities

19.3.9 Threats

19.4 Thermo Fisher Scientific Inc.

19.4.1 Key Facts

19.4.2 Business Overview

19.4.3 Business Segmentation

19.4.4 Revenue Segmentation by Business

19.4.5 Revenue Segmentation by Products

19.4.6 Sales by Geographical Segmentation

19.4.7 Business Strategy

19.4.8 Key Information

19.4.9 SWOT Analysis

19.4.10 Strengths

19.4.11 Weaknesses

19.4.12 Opportunities

19.4.13 Threats

20. Other Reports in this Series



List of Exhibits



Exhibit 1: Market Research Methodology

Exhibit 2: Global Synthetic Biology Market 2013-2018 (US$ million)

Exhibit 3: Global Synthetic Biology Market Segmentation by Technology

Exhibit 4: Global Synthetic Biology Market Segmentation by Technology 2013

Exhibit 5: Global Synthetic Biology Market Segmentation by Product

Exhibit 6: Global Synthetic Biology Market Segmentation by Applications

Exhibit 7: Global Synthetic Biology Market Segmentation by Applications 2013

Exhibit 8: Global Synthetic Biology Market by Geographical Segmentation 2013

Exhibit 9: Synthetic Biology Market in the Americas 2013-2018 (US$ million)

Exhibit 10: Synthetic Biology Market in the EMEA Region 2013-2018 (US$ million)

Exhibit 11: Synthetic Biology Market in the APAC Region 2013-2018 (US$ million)

Exhibit 12: Number of Entities Conducting Research in the Global Synthetic Biology Market 2013

Exhibit 13: Amyris Inc.: Segmentation by Geography 2013

Exhibit 14: Amyris Inc.: Revenue Comparison by Geographical Segmentation 2013-2011 (US$ million)

Exhibit 15: Business Segmentation of DuPont: 2013

Exhibit 16: Revenue Segmentation of DuPont 2013

Exhibit 17: DuPont:Revenue Comparison by business segments for 2013-2011(US$ million)

Exhibit 18: DuPont by Geographical Segmentation 2013

Exhibit 19: DuPont Revenue Comparison by Geography segments for 2013-2011 (US$ million)

Exhibit 20: Business Segmentation of Thermo Fisher Scientific Inc.

Exhibit 21: Revenue by Business Segments of Thermo Fisher Scientific Inc. 2013

Exhibit 22: Revenue by Products of Thermo Fisher Scientific Inc. 2013

Exhibit 23: Sales by Geographical Segmentation of Thermo Fisher Scientific Inc. 2013



 


Enquiry Before Buy
image
Can´t read the image ? refresh here.